Document is current
Any future updates will be listed below
-
Authors
Li, Chengyi https://orcid.org/0000-0003-2378-6408
Ke, Fang
Zhao, Hongyi
Mao, Shuai
Djibo, Mahamadou
Huang, Linqi
He, Miao
Wang, Meilin
Wen, Hanning
Liu, Zhongwei
Yu, Zhixin
Qi, Zhihong
Xavier, Ana R.
Nenwani, Minal
Wen, Bo https://orcid.org/0000-0002-8337-220X
Peterson, Nicole
Sahai, Vaibhav https://orcid.org/0000-0003-1892-1548
Nagrath, Deepak https://orcid.org/0000-0002-8999-2282
Lucas, Carrie L.
Wymann, Matthias P. https://orcid.org/0000-0003-3349-4281
Gao, Wei https://orcid.org/0000-0002-5233-3734
Fong, Lawrence https://orcid.org/0000-0002-6428-428X
Sun, Duxin https://orcid.org/0000-0002-6406-2126
-
Funding
Funding for this research was provided by:
University of Michigan (N035800)
Michigan Strategic Fund
- License Information
-
More Information
Article History
Received: 9 January 2024
Accepted: 23 March 2026
First Online: 28 April 2026
Competing interests
: The University of Michigan has submitted a patent application (PCT/US2024/053672, Dual functioning immune modulating compounds, formulations, and uses thereof), in which some authors (D.S., C.L., W.G., B.W., M.W., M.H., H.Z., S.M., M.D., Z.L., H.W. and F.K.) are listed as inventors. The other authors declare no competing interests.
